Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT
Philippe Gabríel Steg, Deepak L. Bhatt, Ralph T. Doyle, Michael Miller et al.
Citations
1 citations
Journal
European Journal of Preventive Cardiology
Topics
Cardiovascular Function and Risk Factors
Field-Weighted Citation Impact (FWCI)
1.39
article
Benefit of icosapent ethyl across types and sizes of myocardial infarction in REDUCE-IT
Philippe Gabríel Steg, Deepak L. Bhatt, Ralph T. Doyle, Michael Miller, Eliot A. Brinton, Armando Lira Pineda, Chen Gurevitz, Robert P. Giugliano, Jean‐Claude Tardif, Christie Mitchell Ballantyne, Steven Ketchum, Gioacchino Giugliano, Fabrice M A C Martens, Terry A. Jacobson, C. Michael Gibson, R. Preston Mason, Matthew J Budoff
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Preventive Cardiology
Institutions
Brigham and Women's Hospital (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), Emory University (US), Inserm (FR), Baylor College of Medicine (US), Université Paris Cité (FR), University of Utah (US), Montreal Heart Institute (CA), Assistance Publique – Hôpitaux de Paris (FR), Mount Sinai Hospital (US), Baim Institute for Clinical Research (US), Los Angeles Biomedical Research Institute (US), Amarin (United States) (US), Louisville Metabolic and Atherosclerosis Research Center (US), Philadelphia VA Medical Center (US), University of Pittsburgh Medical Center (US), Hôpital Bichat-Claude-Bernard (FR), Hospital El Cruce (AR), Amsterdam University Medical Centers (NL), Bridge Pharma (United States) (US), Université de Montréal (CA), Icahn School of Medicine at Mount Sinai (US)